About: CAPOX-Bevacizumab Regimen     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • CAPOX-Bevacizumab Regimen
rdfs:subClassOf
Semantic_Type
  • Therapeutic or Preventive Procedure
Preferred_Name
  • CAPOX-Bevacizumab Regimen
UMLS_CUI
  • C1879914
Legacy_Concept_Name
  • CAPOX-Bevacizumab_Regimen
FULL_SYN
  • Capecitabine-Oxaliplatin-Bevacizumab RegimenSYNCI
  • CAPOX-Bevacizumab RegimenPTNCI
  • CAPOX-Avastin RegimenSYNCI
DEFINITION
  • A chemoimmunotherapy regimen consisting of capecitabine, oxaliplatin and bevacizumab used as an initial treatment for advanced-stage or metastatic colorectal cancer.NCI
DesignNote
  • Source: NCCN Guidelines 2007
code
  • C63609
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 63 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software